Article Information
History
- July 12, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Johannes J. Kovarik1,*,
- Andrea Bileck2,3,*,
- Gerhard Hagn3,*,
- Samuel M. Meier-Menches2,3,
- Tobias Frey4,
- Anna Kaempf4,
- Marlene Hollenstein4,
- Tarik Shoumariyeh1,
- Lukas Skos3,
- Birgit Reiter4,
- Marlene C. Gerner5,
- Andreas Spannbauer6,
- Ena Hasimbegovic6,
- Doreen Schmidl7,
- Gerhard Garhöfer7,
- Mariann Gyöngyösi6,#,
- Klaus G. Schmetterer4,# and
- Christopher Gerner2,3,#
- 1Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna, Austria
- 2Joint Metabolome Facility, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria
- 3Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Straße 38, 1090 Vienna, Austria
- 4Department of Laboratory Medicine, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna, Austria
- 5Division of Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria
- 6Department of Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Gürtel 18-20, Vienna, Austria
- 7Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
- ↵#Correspondence: christopher.gerner{at}univie.ac.at, klaus.schmetterer{at}meduniwien.ac.at, mariann.gyongyosi{at}meduniwien.ac.at
↵* These authors contributed equally
Posted July 12, 2022.
Multi-omics provide evidence for an anti-inflammatory immune signature and metabolic alterations in patients with Long COVID Syndrome – an exploratory study
